Donald Williams Parsons
Overview
Explore the profile of Donald Williams Parsons including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian G, Courtney A, Yu H, Bhar S, Xu X, Barragan G, et al.
J Immunother Cancer
. 2025 Jan;
13(1).
PMID: 39800376
The ability of immune cells to expand numerically after infusion distinguishes adoptive immunotherapies from traditional drugs, providing unique therapeutic advantages as well as the potential for unmanageable toxicities. Here, we...
2.
Lamoureux A, Fisher M, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm C, et al.
Clin Cancer Res
. 2024 Dec;
31(3):561-572.
PMID: 39625867
Purpose: Tropomyosin receptor kinase (TRK) fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients. Experimental Design:...
3.
Laetsch T, Ludwig K, Williams P, Roy-Chowdhuri S, Patton D, Coffey B, et al.
JCO Precis Oncol
. 2024 Sep;
8():e2400258.
PMID: 39298693
Purpose: Patients age 1-21 years with relapsed or refractory solid and CNS tumors were assigned to phase II studies of molecularly targeted therapies on the National Cancer Institute-Children's Oncology Group...
4.
5.
Burns A, Moore D, Forster C, Powell W, Thammasitboon S, Hostetter M, et al.
J Pediatr
. 2021 Jul;
241:5-9.e3.
PMID: 34280401
No abstract available.
6.
Burns A, Ackerman K, Thammasitboon S, Rassbach C, Ward M, Blankenburg R, et al.
Pediatr Res
. 2020 Mar;
88(2):163-167.
PMID: 32179872
No abstract available.
7.
Seibel N, Janeway K, Allen C, Chi S, Cho Y, Glade Bender J, et al.
Curr Probl Cancer
. 2017 Mar;
41(3):194-200.
PMID: 28343740
With the use of high-throughput molecular profiling technologies, precision medicine trials are ongoing for adults with cancer. Similarly, there is an interest in how these techniques can be applied to...